229 related articles for article (PubMed ID: 22446589)
1. MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis.
Suzuki Y; Sutoh M; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Habuchi T; Arai Y; Fukuda M; Ohyama C; Tsuboi S
Int J Oncol; 2012 Jun; 40(6):1831-8. PubMed ID: 22446589
[TBL] [Abstract][Full Text] [Related]
2. Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity.
Okamoto T; Yoneyama MS; Hatakeyama S; Mori K; Yamamoto H; Koie T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C; Tsuboi S
Mol Med Rep; 2013 Feb; 7(2):359-64. PubMed ID: 23165940
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.
Tsuboi S; Sutoh M; Hatakeyama S; Hiraoka N; Habuchi T; Horikawa Y; Hashimoto Y; Yoneyama T; Mori K; Koie T; Nakamura T; Saitoh H; Yamaya K; Funyu T; Fukuda M; Ohyama C
EMBO J; 2011 Jun; 30(15):3173-85. PubMed ID: 21712812
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for evasion of CTL immunity by altered O-glycosylation of HLA class I.
Sutoh Yoneyama M; Tobisawa Y; Hatakeyama S; Sato M; Tone K; Tatara Y; Kakizaki I; Funyu T; Fukuda M; Hoshi S; Ohyama C; Tsuboi S
J Biochem; 2017 Jun; 161(6):479-492. PubMed ID: 28011817
[TBL] [Abstract][Full Text] [Related]
5. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes.
Beum PV; Singh J; Burdick M; Hollingsworth MA; Cheng PW
J Biol Chem; 1999 Aug; 274(35):24641-8. PubMed ID: 10455130
[TBL] [Abstract][Full Text] [Related]
6. Tumor defense systems using O-glycans.
Tsuboi S
Biol Pharm Bull; 2012; 35(10):1633-6. PubMed ID: 23037152
[TBL] [Abstract][Full Text] [Related]
7. Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase.
Bierhuizen MF; Maemura K; Fukuda M
J Biol Chem; 1994 Feb; 269(6):4473-9. PubMed ID: 8308016
[TBL] [Abstract][Full Text] [Related]
8. Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity.
Nakamura K; Niimi K; Yamamoto E; Ikeda Y; Nishino K; Suzuki S; Kajiyama H; Kikkawa F
Biochem Biophys Rep; 2021 Jul; 26():100951. PubMed ID: 33644424
[TBL] [Abstract][Full Text] [Related]
9. Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice.
Mungul A; Cooper L; Brockhausen I; Ryder K; Mandel U; Clausen H; Rughetti A; Miles DW; Taylor-Papadimitriou J; Burchell JM
Int J Oncol; 2004 Oct; 25(4):937-43. PubMed ID: 15375543
[TBL] [Abstract][Full Text] [Related]
10. O-linked mucin-type glycosylation regulates the transcriptional programme downstream of EGFR.
Tajadura-Ortega V; Gambardella G; Skinner A; Halim A; Van Coillie J; Schjoldager KTG; Beatson R; Graham R; Achkova D; Taylor-Papadimitriou J; Ciccarelli FD; Burchell JM
Glycobiology; 2021 Apr; 31(3):200-210. PubMed ID: 32776095
[TBL] [Abstract][Full Text] [Related]
11. Core 3 mucin-type O-glycan restoration in colorectal cancer cells promotes MUC1/p53/miR-200c-dependent epithelial identity.
Ye J; Wei X; Shang Y; Pan Q; Yang M; Tian Y; He Y; Peng Z; Chen L; Chen W; Wang R
Oncogene; 2017 Nov; 36(46):6391-6407. PubMed ID: 28745318
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1,4-galactosyltransferase IV and beta-1,3-n-acetylglucosaminyltransferase.
Ujita M; McAuliffe J; Schwientek T; Almeida R; Hindsgaul O; Clausen H; Fukuda M
J Biol Chem; 1998 Dec; 273(52):34843-9. PubMed ID: 9857011
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression.
Shimodaira K; Nakayama J; Nakamura N; Hasebe O; Katsuyama T; Fukuda M
Cancer Res; 1997 Dec; 57(23):5201-6. PubMed ID: 9393734
[TBL] [Abstract][Full Text] [Related]
14. Altered Golgi localization of core 2 beta-1,6-N-acetylglucosaminyltransferase leads to decreased synthesis of branched O-glycans.
Skrincosky D; Kain R; El-Battari A; Exner M; Kerjaschki D; Fukuda M
J Biol Chem; 1997 Sep; 272(36):22695-702. PubMed ID: 9278427
[TBL] [Abstract][Full Text] [Related]
15. Implications of altered O-glycosylation in tumour immune evasion.
Itano N
J Biochem; 2019 May; 165(5):387-390. PubMed ID: 30649348
[TBL] [Abstract][Full Text] [Related]
16. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.
Solatycka A; Owczarek T; Piller F; Piller V; Pula B; Wojciech L; Podhorska-Okolow M; Dziegiel P; Ugorski M
Glycobiology; 2012 Aug; 22(8):1042-54. PubMed ID: 22534569
[TBL] [Abstract][Full Text] [Related]
17. Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.
Kinlough CL; Poland PA; Gendler SJ; Mattila PE; Mo D; Weisz OA; Hughey RP
J Biol Chem; 2011 Nov; 286(45):39072-81. PubMed ID: 21937430
[TBL] [Abstract][Full Text] [Related]
18. Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis.
Radhakrishnan P; Grandgenett PM; Mohr AM; Bunt SK; Yu F; Chowdhury S; Hollingsworth MA
Int J Cancer; 2013 Dec; 133(12):2824-33. PubMed ID: 23754791
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design.
Beckwith DM; Cudic M
Semin Immunol; 2020 Feb; 47():101389. PubMed ID: 31926647
[TBL] [Abstract][Full Text] [Related]
20. Expression and localisation of MUC1 modified with sialylated core-2 O-glycans in mucoepidermoid carcinoma.
Sugiura T; Hashimoto K; Kikuta K; Anazawa U; Nomura T; Kameyama A
Sci Rep; 2023 Apr; 13(1):5752. PubMed ID: 37031283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
